Introduction
Cardiovascular disease (CVD) remains as the first cause of death worldwide [1, 2] . It is known that a rising heart failure incidence is associated with unhealthy life styles and increasing life expectance. Current therapies are typically symptomatic and, even though they provide some survival benefit, they cannot reverse the loss of contractile cardiac tissue due to ischemic injury. For this reason, high expectances are associated to the recent developments in stem cell biology and regenerative medicine that promise to replace damaged or lost cardiac muscle with healthy tissue and thus to improve the quality of life and survival in patients with various cardiomyopathies [3] .
The recent identification of different classes of cardiac progenitor cells suggests that the heart, classically considered a terminally differentiated, post-mitotic organ, may rather contain a stem cell compartment, responsible for both tissue turn-over and regeneration, which follows acute or chronic damage to the cardiac tissue [4] [5] [6] . Several groups have already reported the isolation of different types of cardiac stem-like cells based on distinct cell surface markers, such as c-kit, Isl-1 and Sca-1 [7] [8] [9] [10] [11] or the ability to generate genuine cardiomyocytes and integrate into heart tissue as induced pluripotent stem cells [12] , or also in relation to their capacity to influence the neovascularization of the ischemic tissue, as satellite cells [13] . These cells are able to restore cardiac function after ischemic injury, although with variable efficiency [7, 14] . Another type of cells associated with the heart was mesoangioblast, a class of vessel-associated stem cells that can differentiate into various mesoderm cell types. They were originally described in the mouse embryonic dorsal aorta [15] and later similar cells have been identified and characterized from postnatal small vessels of human skeletal muscle [16] and mouse and human heart [4, 17] .
However, the experiments carried out until now were predominantly performed on mice and human. This restricts significantly the possibility to apply the results obtained in preclinical studies that cannot be performed using the human as a model and, at the same time, are limited by the evident differences between mouse and humans, such as their size, mice heart rate and their general anatomy [18, 19] . In particular, human and mouse hearts diverge in the coronary architecture, the variations of which are much bigger in humans compared to mice. As a consequence, whereas the size and location of the ischemic area are fairly constant in the mouse, a much larger variation exists in the human [20] . Differences can also be appreciated at the cellular level, as indicated by the higher capillary density and the larger cross sectional area of the myocytes in human, in comparison to the mouse [21, 22] . Consequently, extrapolation of murine systems, particularly after induction of cardiovascular stress, must be meticulously monitored, when applied clinically, because of the obvious differences between the two systems. In this perspective, a large animal model with higher similarities in term of anatomy, physiology, metabolism and organ development with primates appears mandatory, before moving into clinical heart therapies [23] . The available literature demonstrates many similarities between pig and human heart anatomy [24] [25] [26] and shows that the pig has been widely used as a model in therapy and cardiovascular research as an intermediate animal [27] [28] [29] [30] [31] , offering the ideal link between the classical rodent models and the human and thus representing an experimental tool that may more readily be used and translated in preclinical approaches.
Several recent studies clearly established that the best replacement for the lost myocardium after myocardial infarction (MI) is functional autologous myocardial tissue. However, its derivation form autologus stem cells is too slow and inefficient to be of real benefit in a clinical setting [32] . Therefore it has recently been proposed that a more promising approach to the regenerative medicine is to stimulate the activation of the resident stem cell population [33, 34] . The presence of resident stem cells in the adult heart is well characterized in human and rodents and it has been demonstrated that these cells are more abundant in early post-natal life and decline thereafter [35] .
Therefore, in order to verify if pig can be a suitable model for a therapeutic approach, based on the in situ stimulation of the resident stem cells, aim of this study was to characterize the presence of a resident cell population in the adult pig heart, that we arbitrarily defined Pig Adult Cardiac Progenitors (PACPs). PACPs were isolated from aorta, ventricle and atrium explants and expanded in vitro. They were characterized for the expression of pluripotency as well as mesodermal and cardiac surface markers. In a separate set of experiments, PACPs were tested for their ability to differentiate into mesodermal cell types, with particular interest in their potential to produce functional cardiomyocytes.
Materials and Methods
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich (Milan, Italy). Connexin43 (Cx43) and Lamins A/C primary antibodies cross-react with pig species (as reported in the manufacture datasheet); the specificity of the other antibodies used was previously validated using appropriate pig positive and negative control tissues and false positivity detection was excluded.
Isolation and Culture of Pig Adult Cardiac Progenitors
PACPs were isolated from explants of five healthy adult pig hearts. Ten explants were isolated from aorta, ventricle and atrium of each heart. A total of 30 explants per heart and 50 explants per heart region were obtained. Each piece was rinsed in PBS with Ca 2+ /Mg 2+ and sharply dissected into 1-2 mm diameter pieces. Fragments coming from the aorta and from the outer layers of heart ventricle and atrium were transferred to a Petri dish coated with 0,1% porcine gelatin in presence of Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Italy) supplemented with 10% fetal bovine serum (FBS, Gibco, Italy) plus 1% glutamine and 1% antibiotics (complete DMEM medium). Heart fragments were cultured for 10 days and after the initial outgrowth of fibroblast-like cells, small and round cells appeared. This cell population was easily collected by gently pipetting the original culture and plated on 35 mm Petri dishes (Sarstedt, Germany) pre-coated with 1% porcine gelatin. PACPs were expanded and then characterized by surface marker expression.
Analysis of Pig Adult Cardiac Progenitor Proliferation
PACPs isolated from aorta, ventricle and atrium respectively were plated at a density of 15×10 4 cells/cm 2 in 24 well dishes. Four replicates for every lineage were used in three separate experiments. They were then counted every 3 days for 20 days. Proliferation analysis was carried out using Kova Glasstic® slide (Hycor, UK) and staining cells with Trypan Blue.
Karyotype Analysis of Pig Adult Cardiac Progenitors
Cells were incubated with 10 μg/ml colcemid (Gibco, Italy) for 1 h in a humidified incubator (5% CO 2 , 37°C) and trypsinized. The pelleted cells were incubated in 5 ml hypotonic buffer (0.04 M KCl and 0,025 M citrate sodium) for 20 min at 37°C followed by fixation with methanol/glacial acetic acid (3:1) solution. Fixed cells were dropped on wet slides and air-dried. Giemsa staining was carried out as indicated by manufacturers (KaryoMAX® Giemsa, Gibco, Italy). Metaphases were fully karyotyped under a Leica HC microscope. Images were then captured with digital camera Leica DC250 and using Leica CW4000 Karyo software.
Characterization of Pig Adult Cardiac Progenitor Surface Markers
Three independent replicates of PACPs obtained from the different heart regions were analyzed for surface marker expression. They were washed, fixed with 2% PFA in PBS at room temperature for 45 min and incubated with the specific antibody (see below) at room temperature for 30 min. Flow cytometry was carried out with a FACSCalibur Flow Cytometer (Beckton Dickinson, USA) and analyzed with FACSDiva v6.1.3 software. Cells incubated with primary isotypic antibody were used as a control.
The antibodies used were: R-Phycoerythrin (R-PE)-Conjugated Rat Anti-Mouse CD34 Monoclonal Antibody (BD 
Gene Expression Profiling of Pig Adult Cardiac Progenitors
Five samples obtained from each heart region were used for RT-PCR analysis. Total RNA was isolated with Trizol® Reagent (Invitrogen, Italy) and reverse transcribed, using SuperScript® II Reverse Transcriptase (Invitrogen, Italy) following the manufacturer's instruction. Amplifications were carried out in an automated thermal cycler (iCycler, Bio-Rad, Italy), with the conditions appropriate for each set of primers. PCR primers were designed using the oligo program Primer3 Input. RT-PCR products were run in a 2% agarose gel. c-Kit, LY6G6F (Sca-1), Oct4, Nanog, Sox-2, Gata6, CD31, CD34, CD44, Mesp1, Mesp2, Mef2a, Nkx2.5, ANP, Cx43, Cardiac Actinin, Tbx5, Tbx18, MyoD and Myf5 primers were designed based on NCBI pig genome databank (Table 1) . Positive control was carried out using genomic DNA or cDNA obtained from the appropriate tissue, depending on the gene (see Table 2 for details). Expression of β-actin was always examined as an internal control of the sample quality. To confirm the identity of the RT-PCR fragments, amplification products from each primer pair were separated by gel electrophoresis in 2% agarose gels, purified using Spin-X centrifuge tube filters (Corning, Italy), sequenced (SEQLAB, Gottingen, Germany) and aligned using Clustal W 1.82 (EMBL-EBI service).
Pig Adult Cardiac Progenitor Differentiation Assays
Cardiac differentiation ability of PACPs was assessed by plating cells in 4 well dishes at a concentration of 2,5×10 5 cells/cm 2 in DMEM, supplemented with 2% FBS, 1% Lglutamine, 1% penicillin/streptomycin and 10 μM of 5'-azacytidine. The differentiation medium was changed every 48 h for 7 days. Differentiation ability into smooth muscle cells was also tested. In order to address PACPs towards this commitment, the same medium described above was used but in the latter 5 ng/ml of transforming growth factor beta (TGFβ; PeproTech, Inc, USA) replaced 5'-azacytidine. Skeletal muscle differentiation ability was assessed by coculturing PACPs with C2C12 cells at a rate of 1:5 respectively for 7 days.
Immunocytochemistry and Immunofluorescence
Four well dishes containing PACPs were washed with PBS, and fixed with 4% paraformaldehyde for 10 min at 4°C. Cells were permeabilized with 0.1% Triton X-100, rinsed with 0.1% PBS-Tween and then nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) for 30 min. Markers of mesenchymal and cardiac stem cells were assessed by immunocytochemistry using the following primary antibodies: Desmin (1:200, mouse monoclonal, MAB1698, Chemicon, USA); Cx43 (1:2000, rabbit polyclonal, sc-9059, Santa Cruz, USA); Smooth Muscle Actin (SMA, 1:800, mouse monoclonal, sc-53015, Santa Cruz, USA); MF20 (1:200, mouse monoclonal, SAB4700663, Sigma, Italy) and Lamins A/C (1:200, mouse monoclonal, NCL-LAM-A/C clone 636, Novocastra, UK). Primary antibodies were diluted in blocking solution (10% serum in PBS) and were used to stain PACPs overnight at 4°C. Cells were then incubated with the appropriate secondary antibodies for 45 min at room temperature (goat anti-rabbit 488 and donkey anti-mouse 594 Alexafluor, Invitrogen, Italy); nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI). Samples were observed either under an Eclipse TE200 (Nikon, Japan) or an Eclipse E600 microscope (Nikon, Japan). Images were captured with the Digital Sight camera DS-2MBWc (Nikon) and analyzed with NISElements F 3.00 (Nikon).
Pig Adult Cardiac Progenitors Co-cultured with Fetal Rat Cardiomyocytes
Fetal cardiomyocytes were obtained from 21 days old wild-type rat embryos. Hearts were removed and the ventricles were dissected and digested with collagenase type II (108 U/ml, Worthington Biochemical Corporation, USA) and with pancreatine (0.6 mg/ml, Gibco, Italy) for 20 min at 37°C. Cells were collected by centrifugation and resuspended in newborn calf serum (NBCS; Gibco, Italy). These steps were repeated until the ventricles were completely digested. Cells were collected and subjected to centrifugation through a discontinuous Percoll gradient. The middle band containing cardiomyocytes was collected. Cells were counted with Burker's chamber and then were placed on gelatincoated 35-mm plastic tissue culture plates at a density of 5×10 4 /50 μl in a culture medium consisting of a 4:1 mixture of DMEM and medium 199 supplemented with 10% HS and 5% FBS, 1% L-glutamine and 1% penicillin/streptomycin. These cells were maintained at 37°C. Cultures were then shifted, 24 h after plating, to a maintenance medium containing both HS and FBS to a final concentration of 5% and 1% cytosine arabinoside (Ara-C, 10 mM) to kill fibroblasts and endothelial cells (all medium were from Gibco). 48 h after the plating of the cardiomyocytes, PACPs were added at different concentrations for 5 days. Cells were incubated with an antibody that specifically recognizes Lamins A/C of pig nuclei and does not react with rat cells. All nuclei were stained with DAPI. Fusion phenomena were scored randomly choosing 10 microscopy field and averaged. Samples were observed under an Eclipse E600 microscope (Nikon, Japan).
Data Analysis
All experiments were carried out three times using four replicates each and subjected to statistical analysis using ANOVA (SigmaStat). Errors were presented as 
standard deviation (SD). Data with a p value <0.05 were considered statistically significant. In flow cytometry studies at least 10.000 events for each sample were counted.
Results

Isolation and Proliferation Ability of Pig Adult Cardiac Progenitors
After an initial outgrowth of fibroblast-like cells, within 10 days from explant plating, small and poorly adhering cells appeared and could be detached by gently pipetting (Fig. 1a-c) . Cultures of this cell population was carried out and maintained in complete DMEM medium. We could observe that PACPs were efficiently and reproducibly obtained from aorta, ventricle and atrium. These cells were termed aortic, ventricular and atrial PACPs (Fig. 1d-f ). They had a doubling time of 35 h and kept a relatively slow proliferation rate for approximately 25 passages. They achieved senescence after 28 passages, when large cells appeared at increasing frequency that did not divide anymore (data not shown). Aorta-and ventricle-derived PACPs proliferated faster than cells isolated from atrium (Fig. 1g) .
Karyotype Analysis of Pig Adult Cardiac Progenitors
Cultured PACPs were genetically stable displaying the euploid number of 38 chromosomes (Fig. 2a-b) . Karyotype analysis was performed at 14 and 25 passages and confirmed PACP genetic stability, excluding the presence of anomalies that could be caused by prolonged in vitro culture (Fig. 2c) .
Characterization of Pig Adult Cardiac Progenitor Surface Markers
All cell lines were positive for the surface marker CD34 and CD44 in flow cytometry analysis. A subpopulation of the analyzed cells expressed CD31 (namely 17.05% of the cells in the lines obtained from aorta, 5.38% in those derived from ventricle and 8.33% of the atrium derived populations). Screening for CD45 gave a negative result in all cells of all the lines obtained, regardless to their origin. Expression of Alkaline Phosphatase (AP) was restricted to a small subpopulation (2%) of cells obtained from aorta (Fig. 3a, Table 3 ).
Pig Adult Cardiac Progenitors Express Stem and Cardiac Markers
RT-PCR experiments performed on RNA extracted from PACPs deriving from all the different heart regions considered, demonstrated the expression of genes related to pluripotency as well as involved in mesodermal and cardiac development (Fig. 3b, Table 2 ). In particular, PACPs expressed c-Kit, Gata6, CD44, Mesp1, Mef2a and ANP while transcription of Mesp2 and Nkx2.5 was detected only in aorta-and ventricular-derived cells.
PACPs expressed some early endothelial markers such as CD31, suggesting a possible endothelial origin for these cells. Similarly, transcription of CD34 indicated a correlation with circulating vascular progenitor cells.
RT-PCR analysis also demonstrated the expression of genes distinctive of epicardial progenitors such as Tbx5 and Tbx18. Furthermore, PACPs were positive for the pluripotency related marker Oct4, implying that these cells might belong to a residing cardiac stem cell population. On the other hand, no expression of Nanog, Sox-2 and LY6G6F (Sca-1) was detected. When exposed to the appropriate inducing media, PACPs showed positivity for Cx43 and Cardiac Actinin, while skeletal myogenic markers such as MyoD or Myf5 were negative in all cell lines.
Differentiation Ability of Pig Adult Cardiac Progenitors
PACPs did not spontaneously differentiate into beating cardiomyocytes, even when cultured with a medium containing low serum, which has been previously shown to trigger this event in mice [10] . By contrast, they predominantly differentiated into cardiomyocytes when Fig. 3 Expression of surface markers by flow cytometry. Three independent replicates of PACPs obtained from the different heart regions were analyzed for the presence of CD34, CD44, CD31, CD45 and AP (a); expression of the genes c-Kit, LY6G6F (Sca-1), Oct4, Nanog, Sox-2, Gata6 (left column), CD31, CD34, CD44, Mesp1, Mesp2, MyoD, Myf5 (middle column), Mef2a, Nkx2.5, ANP, Cx43, Cardiac Actinin, Tbx5 and Tbx18 (right column), was investigated in samples from aorta, ventricle and atrium obtained from five different hearts. In negative controls Reverse Transcriptase was omitted. The appropriate positive control was used, depending on the gene considered (see Table 2 ). Expression of β-actin was always examined as an internal control of the sample quality treated with 10 μM 5'-azacytidine. Staining with an anti-Desmin antibody showed PACP ability to progress to mesenchymal cell lineage with 96% of aorta cells, 89% of ventricle cells and 74% of atrium cells displaying positivity ( Fig. 4a-d) . Similarly, the use of an anti-Cx43 antibody, demonstrated that 61% of aorta cells, 30% of ventricle cells and 32% of atrium cells formed cardiomyocytes (Fig. 4e-h ). Furthermore, a poor ability (less than 1%) to differentiate into skeletal muscle, was demonstrated when PACPs were stained with the specific MF20 antibody (data not shown). In contrast, they were able to differentiate into smooth muscle cells in response to 5 ng/ml TGFβ with 72% of aorta cells, 58% of ventricle cells and 71% of atrium cells and were immunopositive for SMA (Fig. 4i-l) . Co-culture with fetal rat cardiomyocytes demonstrated PACP ability to give rise to fusion events. However, this property appeared to be limited to aorta-and ventricle-derived PACPs that gave rise to 5% fusion rate with rat cardiomyocytes (Fig. 5) . Atrium-derived cells appeared to lack this ability since no fusion event was detected (data not shown).
Discussion
In the present manuscript, we report the derivation of adult cardiac progenitors from adult healthy pig hearts. We show the possibility to isolate cardiac progenitors from 3 different heart regions, such as aorta, ventricle and atrium, respectively. This observation indicates that this subpopulation of committed, but still proliferating, cardiac progenitor cells is not confined to a specific region within the organ, but rather distributed to several areas. Interestingly enough, however, PACPs are unlikely to derive from inner regions since the starting explants were obtained from the outer layers of the organ. This is consistent with experimental evidence, indicating the epicardium as a possible site of origin for resident stem or progenitor cell populations in the mouse and in the human [36] [37] [38] [39] [40] . PACPs were able to grow in vitro until senescence and displayed a chromosomal set up typical of the porcine species. A normal karyotype was preserved unaffected along the culture passaging, suggesting that the protocol used to isolate, maintain and propagate PACPs in vitro was not affecting cell stability and/or inducing chromosomal alterations.
Unexpectedly, PACPs expressed the pluripotency marker Oct4 (Fig. 3b, Table 2 ). The expression of Oct4 was already reported in the literature in mammalian heart by Torella et al. This group proposed that specific regions, defined harbours, contain Oct4 positive cells that belong to the cardiac stem cell pool and may represent the true resident stem cells in the organ. These cells were described to be able to differentiate into real cardiomyocytes, smooth muscle cells, endothelial cells and in other mesoderm cell types when grown in the appropriate media [41] . Although this must be further investigated, we may hypothesize that PACPs might belong to this residing cardiac stem cell population.
At the same time, PACPs showed the expression of genes specific of mesenchymal stem cells (MSCs), such as CD44 [42] , Mesp1 [43, 44] and Mesp2 [44] (Fig. 3b, Table 2 ). This indicates that PACPs are likely to have a mesodermal origin and display part of the transcription pattern, which has been previously described in mouse and human MSCs [43] [44] [45] [46] . Furthermore, similarly to MSCs, that have the capability to differentiate into different mesoderm-related cell types, including muscle tissue [45, 46] , PACPs were able to efficiently differentiate into smooth muscle cells in response to TGFβ, with a high percentage of cells displaying immunopositivity for SMA (Fig. 4i-l) . In contrast, gene expression analysis of PACPs did not show skeletal myogenic-related transcripts, such as MyoD and Myf5 [7, 17] (Fig. 3b, Table 2 ), indicating the inability of these cells to differentiate into striated muscle tissue. It is however interesting to note that the concomitant expression of specific endothelial and hematopoietic markers, such as CD31 and CD34 (Tables 2 and 3) , suggests a possible vascular origin or a close association with the vessel wall of PACPs. This is in agreement with data previously described that shows the isolation from mice of a cell population that has the ability to differentiate into cardiomyocytes, endothelial cells and vascular smooth muscle cells [17, 47] . On the other hand, PACP expression of the T-box genes Tbx18 and Tbx5, which are expressed in the epicardial cell layer of the heart and its progenitors [48] [49] [50] [51] , suggests that PACPs may belong to an epicardial progenitor population (Fig. 3b, Table 2 ).
Although PACPs share some molecular and functional properties with MSCs, they also express genes representative of early and late cardiac transcription factors, such as Gata6 [52] , Mef2a [53] , Nkx2.5 [54, 55] and ANP [56, 57] (Fig. 3b, Table 2 ), indicating that they are part of a progenitor population addressed to the formation of cardiac mesoderm [58] . This gene expression pattern is possibly involved in conferring PACPs their ability to respond to specific stimuli and further differentiate along the cardiac lineage. Indeed, consistent with previous experiments carried out in human mesoangioblasts, human embryonic stem cells and human MSCs [4, 59, 60] , PACPs were unable to spontaneously develop into beating cardiomyocytes, as it happens in the mouse [17, 61] . On the other hand, after exposure to 5'-azacytidine, they progressed to cells that were positive for Cx43 [62, 63] and Cardiac Actinin [64] (Fig. 3b) , which are typical of differentiated cardiomyocytes and are required to establish intercellular connections between atrial and ventricular myocytes and essential for cardiac contraction [64] [65] [66] . These findings altogether indicate PACP higher similarity with cardiac progenitors derived from the human species [4, 59, 60] . Several authors have considered in the recent years fusion ability as a marker of differentiation in vitro [4, 15, 17, 67, 68] . Indeed, cell fusion experiments further demonstrated PACP ability to differentiate in vitro and to give rise to fusion events, reflecting a distinct property common to many types of cardiac progenitors, although this property appeared to be limited to aorta-and ventriclederived cells (Fig. 5) . In particular, PACPs showed 5% rate of fusion events, consistent with previous data obtained using different cell types, such as mouse embryonic stem cells, human MSCs and human cardiac stem cells, that reported similar fusion efficiency [46, 69, 70] . On the other hand, much higher fusion rate has been previously described for human and mouse mesoangioblasts [4, 17] . Although we have no ready explanation for this variability, we may hypothesize that different cell types may lead to dissimilar fusion results. Furthermore, species-related diversities cannot be ruled out. In the last few years, several groups described many different cardiac stem/progenitor cells in different species with high phenotypic and molecular variability. It is unclear whether they represent specific differentiation stages of a common multipotent cardiovascular progenitor cell population, whether they result from different methods of isolation, culture media and anatomical origin or whether they are genuine, distinct and specific cardiac progenitors, co-existing in the organ. Cardiogenic stem cells of porcine origin have been object of intense studies. In particular, mesenchymal stem cells obtained in this species have been widely used to explore new delivery methods [71] and resulted in successful engraftment and differentiation into cardiomyocytes [72] . Cardiogenic stem cells have also been derived from pig adipose tissue [73] and from amniotic fluid-derived mesenchymal cells [74] . During the preparation of the present manuscript an exhaustive study has reported the isolation of a c-Kit + /CD45
− cardiogenic cell population from weanling pigs [35] , demonstrating a robust regenerative effect of these cells that are most likely involved in the myocardium hyperplastic growth and maturation to adulthood, consistent with data previously shown in neonatal mice [75] . PACPs display a high molecular affinity and share many differentiation abilities with this resident cardiac c-Kit
− progenitor cell population. Altogether, the data presented in our manuscript indicate the possibility that, although more abundant and active in the neonatal and post weaning period, cells with cardiogenic properties can be isolated in the adult porcine heart. 
